Safety and Efficacy of Entospletinib With Vincristine and Dexamethasone in Adults With Relapsed or Refractory Acute Lymphoblastic Leukemia (ALL)

PHASE1/PHASE2TerminatedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 6, 2015

Primary Completion Date

November 16, 2018

Study Completion Date

December 17, 2018

Conditions
Acute Lymphoblastic Leukemia
Interventions
DRUG

Entospletinib

DRUG

Vincristine

DRUG

Dexamethasone

DRUG

CNS Prophylaxis

Trial Locations (13)

10021

Memorial Sloan-Kettering, New York

12200

Medizinische Klinik mit Schwerpunkt Hepatologie & Gastroenterology, Berlin

29601

Bon Secour St. Francis Hospital, Greenville

43210

The Ohio State University, Columbus

60637

University of Chicago, Chicago

90095

UCLA, Los Angeles

91010

City of Hope, Duarte

92093

University of California San Diego (UCSD), San Diego

92608

UC Irvine Medical Center, Orange

98109

University of WA, Seattle

07601

Hackensack University Medical Center, Hackensack

Unknown

Princess Margaret, Toronto

Medizinische Klinik und Poliklinik I, Würzburg

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Gilead Sciences

INDUSTRY